Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

2 Apr 2009 07:00

RNS Number : 9670P
Intercede Group PLC
02 April 2009
 



APRIL 2009

INTERCEDE GROUP PLC

("Intercede" or "the Company")

Trading Update for the Full Year to 31 March 2009

Further to Intercede's Trading Update on 5 February 2009, we are pleased to report that the Company is continuing to experience high levels of interest in and demand for its MyID technology

Pre audit indications of the results for the year ended 31 March 2009 are that revenues are likely to be more tha90ahead of the previous year's reported revenues of £2.8m. A full year profit has been achieved for the first time in the Group's history and earnings before interest and tax are anticipated to exceed £1m. As a result of this performance, the cash balance at 31 March 2009 was £3.7m, compared to £1.2m at the same time last year.

This acceleration in Intercede's growth reflects the continued momentum from the Company's involvement in an increasing number of projects around the world with a consequential increase in revenues from software license sales, associated support & maintenance and the delivery of ongoing professional services assistance. 

Intercede Chairman and Chief Executive Richard Parris said, "I am pleased to report a strengthening in demand for Intercede's products from both national governments and large enterprise customers. This is generating attractive financial returns at a time when general economic conditions around the world are difficult."

Intercede expects to announce its full year results for the year ended 31 March 2009 by mid June 2009.

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Tel. +44 (0)20 7600 1658

Charles Cunningham

Pelham Public Relations

Archie Berens

Tel. +44 (0)20 7337 1509

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a programme with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

Intercede and MyID are registered trademarks or trademarks in the UK, US and/or other countries. For more information visit http://www.intercede.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSLFMFSUSEDL
Date   Source Headline
15th Dec 20057:00 amRNSInterim Results
12th Dec 200512:28 pmRNSRe New OEM Agreement
9th Dec 200512:47 pmRNSHolding(s) in Company
30th Nov 200510:42 amRNSFurther re OEM Agreement
21st Nov 20051:44 pmRNSFurther re Global OEM Licence
12th Sep 20057:00 amRNSRe: Global OEM Licence
13th Jun 20054:12 pmRNSHolding(s) in Company-Amend
25th May 200512:04 pmRNSHolding(s) in Company
24th May 20057:00 amRNSFinal Results
31st Mar 20057:00 amRNSTrading Statement
24th Feb 200512:48 pmRNSRe Contract
21st Jan 20059:11 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.